Sellayah Renishka, Pande Girish
Department of Surgery, Launceston General Hospital, 274-280 Charles Street, Launceston, 7250, Tasmania, Australia.
Surg Pract Sci. 2025 Mar 17;21:100279. doi: 10.1016/j.sipas.2025.100279. eCollection 2025 Jun.
Oesophagectomy is recommended as part of curative treatment for oesophageal cancer but is associated with substantial morbidity. Centralization has been recommended to improve outcomes, but this has not been widely applied in Australia. This study aimed to audit a regional hospital's experience over ten years and compare it to outcomes from national and international centres to support the view that oesophagectomy can be performed safely in select regional centres in Australia.
Patients undergoing oesophagectomy at a single regional hospital in North-East Tasmania, Australia between January 2014 and December 2023 were retrospectively identified. Preoperative patient and tumour characteristics, and outcomes (mortality, anastomotic leak, length of stay, respiratory complications, long-term complications and survival) were compared to other centres.
65 patients were identified. 53 % were male, mean age was 65.2 years, 29.2 % had respiratory disease and 18.5 % were current smokers. The anastomotic leak rate was 7.7 %. 25 % developed pneumonia postoperatively. Average ICU length of stay was 4.6 days, median acute inpatient length of stay was 15 days. There was one in-hospital mortality and one 30-day mortality. 2 patients (3 %) required diaphragmatic hernia repair; 12 patients (18.5 %) required endoscopic dilatation of anastomotic strictures. The 5-year survival rate was 66 %. Our results compare favourably to published rates of anastomotic leak (10-15 %), inpatient stay (15 days), pneumonia (20-30 %), 30-day mortality (1-4 %) and anastomotic stricture (20 %).
Oesophagectomies can be safely performed in regional centres in Australia that routinely undertake a higher volume of cases per year, provided services required to manage complications are readily available.
食管切除术被推荐作为食管癌根治性治疗的一部分,但会带来较高的发病率。有人建议集中化治疗以改善治疗效果,但这在澳大利亚尚未得到广泛应用。本研究旨在审核一家地区医院十年间的经验,并将其与国内和国际中心的治疗结果进行比较,以支持在澳大利亚特定地区中心可以安全开展食管切除术的观点。
回顾性确定2014年1月至2023年12月期间在澳大利亚塔斯马尼亚州东北部一家地区医院接受食管切除术的患者。将患者术前特征和肿瘤特征以及治疗结果(死亡率、吻合口漏、住院时间、呼吸并发症、长期并发症和生存率)与其他中心进行比较。
共确定65例患者。其中53%为男性,平均年龄65.2岁,29.2%患有呼吸系统疾病,18.5%为当前吸烟者。吻合口漏发生率为7.7%。25%的患者术后发生肺炎。重症监护病房平均住院时间为4.6天,急性住院患者中位住院时间为15天。有1例院内死亡和1例30天死亡。2例患者(3%)需要进行膈疝修补;12例患者(18.5%)需要进行吻合口狭窄的内镜扩张。5年生存率为66%。我们的结果与已发表的吻合口漏发生率(10%-15%)、住院时间(15天)、肺炎发生率(20%-30%)、30天死亡率(1%-4%)和吻合口狭窄发生率(20%)相比更优。
在澳大利亚每年常规开展较多病例的地区中心,可以安全地进行食管切除术,前提是具备处理并发症所需的服务。